Zydus Lifesciences Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
One of their notable products is RANOLAZINE (PROCESS II), with a corresponding US DMF Number 29736.
Remarkably, this DMF maintains an Active status since its submission on January 01, 2016, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of March 09, 2016, and payment made on December 21, 2015, indicating their dedication to facilitating drug approvals, Categorized as Type II